Zafirlukast

DRUG4 trials

Sponsors

Dr. Reddy's Laboratories Limited, University of California, San Francisco, Beth Israel Deaconess Medical Center, Allergy & Asthma Medical Group & Research Center

Conditions

Allergy to CatsBreast CancerHealthyOvarian Cancer

Phase 1

Bioequivalence Study of Zafirlukast Tablets 20 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition

CompletedNCT01283061

Dr. Reddy's Laboratories LimitedHealthy

Start: 2007-12-31End: 2008-01-31Updated: 2011-01-26

Phase 2

Breast Capsular Contracture Following Post-Mastectomy Reconstruction in Women Treated With the Leukotriene Inhibitor Zafirlukast: A Phase II Trial

TerminatedNCT02950480

University of California, San FranciscoBreast Cancer

Start: 2017-03-13End: 2018-12-20Updated: 2019-10-01

Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer

CompletedNCT04339140

Beth Israel Deaconess Medical CenterOvarian Cancer

Start: 2020-06-24End: 2024-12-31Updated: 2025-12-11

Crossover Study of Zafirlukast in Preventing Allergen-induced Signs and Symptoms in Response to Cat Dander Challenge

Not yet recruitingNCT06069063

Allergy & Asthma Medical Group & Research CenterAllergy to Cats

Start: 2025-12-05End: 2026-07-31Target: 12Updated: 2025-09-22